PUBLISHER: IMARC | PRODUCT CODE: 1298787
PUBLISHER: IMARC | PRODUCT CODE: 1298787
The global blood processing devices and consumables market size reached US$ 48.68 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 75.22 Billion by 2028, exhibiting a growth rate (CAGR) of 7.40% during 2023-2028. The rising demand for blood and its products, supportive policies by governmental and non-governmental organizations, and the recent development of a closed blood sampling system represent some of the key factors driving the market.
Blood processing devices and consumables refer to tools and materials used in the collection, processing, and transfusion of blood and its products. It includes tubes, bags, centrifuges, vials, freezers, filters, needles and syringes, blood culture systems, and plasma thawing devices. They are manufactured using various materials, such as plastic, glass, rubber, stainless steel, and titanium. Blood processing devices and consumables are widely used for blood storage, transport, separation, filtering, typing and cross-matching, irradiation, apheresis, and blood processing system. They enhance safety, increase efficiency, extend blood shelf-life, and minimize the risk of contamination, infections, and transfusion-related complications. Blood processing devices and consumables also aid in maintaining quality standards, reducing wastage, eliminating the need for manual sample handling, and ensuring the availability of blood and its products to healthcare facilities.
The rising demand for blood and its various products, such as white blood cells (WBCs), red blood cells (RBCs), and plasma, due to increasing numbers of surgical procedures, is one of the primary factors propelling the market growth. Blood processing devices and consumables are widely used in healthcare facilities to collect, process, transport, and store blood products, as they ensure safety, improve clinical efficiency, enhance patient safety, maintain blood efficacy, and prevent contaminations. In addition to this, the growing number of blood-related disorders, such as sickle cell anemia and thalassemia, is acting as another growth-inducing factor. Furthermore, the implementation of supportive policies by governmental and non-governmental organizations to promote blood donation, educate the masses, and provide funding for blood collection and processing programs is positively influencing the market growth. Additionally, the recent development of a closed blood sampling system, which utilizes a needleless connection between the blood collection set and the blood bag to reduce the risk of infection, contamination, and needlestick injuries, is providing an impetus to the market growth. Besides this, the introduction of automated blood processing systems, which carry out multiple steps simultaneously, thus improving overall efficiency, reducing manual labor, minimizing operational costs, and saving time, is contributing to market growth. Moreover, the rising demand for point-of-care testing that allows healthcare professionals to perform blood tests and collect samples quickly at patients' homes is strengthening the market growth. Other factors, including the rapid expansion of the healthcare industry, increasing investments in the development of advanced devices, and the rising number of trauma cases, such as accidents, violence, and natural disaster, are anticipated to drive the market growth.
IMARC Group provides an analysis of the key trends in each segment of the global blood processing devices and consumables market, along with forecasts at the global, regional, and country levels from 2023-2028. Our report has categorized the market based on product and end user.
Blood Processing Devices
Blood Bank Freezers
Blood Grouping Analyzers
Blood Warmer
Blood Cell Processers
Others
Blood Processing Consumables
Blood Bags
Blood Lancets
Vials
Blood Administration Sets
Others
The report has provided a detailed breakup and analysis of the blood processing devices and consumables market based on the product. This includes blood processing devices (blood bank freezers, blood grouping analyzers, blood warmer, blood cell processers, and others) and blood processing consumables (blood bags, blood lancets, vials, blood administration sets, and others). According to the report, blood processing devices represented the largest segment.
Hospitals and Clinics
Diagnostic Laboratories
Others
A detailed breakup and analysis of the blood processing devices and consumables market based on the end user has also been provided in the report. This includes hospitals and clinics, diagnostic laboratories, and others. According to the report, hospitals and clinics accounted for the largest market share.
North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for blood processing devices and consumables. Some of the factors driving the North America blood processing devices and consumables market included rising demand for blood and its products, favorable government policies, and rapid technological advancements.
The report has also provided a comprehensive analysis of the competitive landscape in the global blood processing devices and consumables market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include Abbott Laboratories, BioMerieux SA (Institut Merieux), Bio-Rad Laboratories Inc, Danaher Corporation, Grifols S.A., Haemonetics Corporation, Macopharma, Roche Holding AG, Terumo Corporation, Thermo Fisher Scientific Inc., ThermoGenesis Holdings, Inc., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.